Annual IFRUE Meeting
August 14 to August 17, 2025
Sheraton Downtown Denver Hotel
1550 Court Pl, Denver, CO 80202

Deadline:  July 1, 2025

Video Abstract Guidelines

  • The recommended abstract length is 250 words or less, excluding the title and authors’ names.
  • Abstract title should be descriptive (200 characters or less). Tables and figures are not allowed.
  • The primary/submitting author will receive an email confirming receipt of the abstract. Please notify your co-authors that the confirmation was received.

Procedures and Deadlines

  • All abstracts must be received by Tuesday, July 1, 2025. Abstracts are approved for presentation and inclusion in the annual scientific program at the recommendation of the 2025 Program Committee.
  • Disclosures for ALL authors/co-authors are required within the submission form and their institutions, city, state, country, etc.
  • Do not include tables or figures in your abstract.
  • Please note only the authors’ and institutions’ names in the specified fields within the abstract form.
  • Complete speaker and paper presentation instructions will be provided upon notification of a paper’s acceptance.

Video Guidelines

  • There must be only one subject per presentation
  • Maximum size is 120MB
  • All digital videos must be recorded in English and have some sound; music is not required
  • The opening frames of the video presentation must begin with the exact title and include the authors’ names
  • Submissions of exceedingly commercial presentations are discouraged, and such submissions are less likely to be accepted for presentation.
  • Submissions funded by commercial companies must be identified in a disclaimer at the start of the presentation.
  • Digital video presentations that are longer than 8 minutes will automatically be rejected.

Allowed video types: .mov, .mp4

IFRUE Contact Information
All Abstract questions should be directed to Josie Mendez at [email protected]

IFRUE is not responsible for the content of each presentation, which does not represent IFRUE’s opinions.

Abstract Guidelines

Abstract Submission

  • All submissions must be made via the IFRUE website www.ifrue.org by July 1, 2025
  • The IFRUE Scientific Committee will decide on the presentation category for presentation abstracts.
    • Abstract Presentation
    • E-Poster
  • All accepted abstracts will be published on the IFRUE website exactly as submitted.
  • Podium Presentations will be published in an open-access journal or digital media.
  • Unpublished abstracts previously presented at other meetings may be considered.
  1. Anonymity for most objective reviews
  • The abstract text must be anonymous. i.e., without any authors’ or institutions’ names. Do not include the name of the hospital, university or city.
  • All abstract identification details, references, ethical approval, and disclosures will be taken separately during the online submission process and merged with the abstract text after review.
  1. Disclosures and funding
  • Any external funding of the study or grants must be declared or stated as NONE.
  1. Abstract Formatting and Subtitles
  • The format requested must be at least 300 words but not more than 600 words.
  • Do not use characters or symbols from any font set other than Arial.
  • Images, figures, graphs and tables can be uploaded with a maximum total of 2 per abstract.
  • Abstracts must use the sections given:
    • Hypothesis/aims of study
    • Study design, materials, and methods
    • Results
    • Interpretation of results
    • Concluding message
  • Missing sections will cause rejection.
  1. Abstract Content.
  • Studies must not be split into multiple abstracts. This could lead to each abstract being downgraded.
  • Preliminary Data will be considered.
  • Abstracts must specify either:
    • Pure and Applied Science / Translational
    • Clinical
  • Abstracts must specify one Broad Category  as detailed below:

Categories

Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction / BPH

Sexual Dysfunction

Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction / UTI

Female Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse

Male Stress Urinary Incontinence (Post Prostatectomy Incontinence)

Overactive Bladder

Neurourology

Lower Urinary Tract Stricture/Fistula

Upper Urinary Tract Stricture